← Back
Data updated: Mar 29, 2026
SCIEGEN PHARMS
CardiovascularImmunologyGastroenterology
Generics
SCIEGEN PHARMS is a generic drug manufacturer focused on Cardiovascular, Immunology, Gastroenterology.
1975
Since
88
Drugs
-
Trials
1295
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
GABAPENTIN 2026-02-24
Labeling
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 38%
8 drugs
Immunology 24%
5 drugs
Gastroenterology 19%
4 drugs
Neurology 10%
2 drugs
Oncology 10%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology
Active (42)
RIVAROXABAN DROXIDOPA NAPROXEN AND ESOMEPRAZOLE MAGNESIUM TICAGRELOR EZETIMIBE AND SIMVASTATIN OLMESARTAN MEDOXOMIL ROSUVASTATIN CALCIUM ARIPIPRAZOLE CELECOXIB SOLIFENACIN SUCCINATE RALOXIFENE HYDROCHLORIDE RANOLAZINE IRBESARTAN ATORVASTATIN CALCIUM LEVOCETIRIZINE DIHYDROCHLORIDE OMEPRAZOLE AND SODIUM BICARBONATE TAMSULOSIN HYDROCHLORIDE LEVETIRACETAM DIVALPROEX SODIUM VENLAFAXINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE LAMOTRIGINE FEXOFENADINE HYDROCHLORIDE HIVES FEXOFENADINE HYDROCHLORIDE ALLERGY LISINOPRIL LEVOCARNITINE NABUMETONE DESOXIMETASONE NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE DICLOFENAC SODIUM CROMOLYN SODIUM METOPROLOL TARTRATE NAPROXEN SODIUM CLOTRIMAZOLE CHLORHEXIDINE GLUCONATE HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE AMINOCAPROIC ACID ACETIC ACID NYSTATIN PHYTONADIONE FLUOCINONIDE HYDROCHLOROTHIAZIDE
Discontinued (45)
BUPROPION HYDROCHLORIDE GABAPENTIN PREGABALIN DILTIAZEM HYDROCHLORIDE METRONIDAZOLE AMLODIPINE BESYLATE GLYCOPYRROLATE LACOSAMIDE FLUOXETINE HYDROCHLORIDE QUETIAPINE FUMARATE MECLIZINE HYDROCHLORIDE POTASSIUM CHLORIDE CLOBETASOL PROPIONATE DIPHENHYDRAMINE HYDROCHLORIDE METFORMIN HYDROCHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE TRIAMCINOLONE ACETONIDE NAPROXEN FLUOCINOLONE ACETONIDE CLOPIDOGREL BISULFATE MEMANTINE HYDROCHLORIDE PIRFENIDONE PRAMIPEXOLE DIHYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE VALSARTAN METAXALONE AMLODIPINE AND OLMESARTAN MEDOXOMIL HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE HYDROCODONE BITARTRATE AND PSEUDOEPHEDRINE HYDROCHLORIDE LACTULOSE CARBIDOPA AND LEVODOPA CARISOPRODOL EZETIMIBE LEVOFLOXACIN AZELASTINE HYDROCHLORIDE LITHIUM CITRATE GENTAMICIN SULFATE NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC DIFLORASONE DIACETATE ETHACRYNIC ACID BACITRACIN ZINC AND POLYMYXIN B SULFATE CYCLOPENTOLATE HYDROCHLORIDE NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN NEMBUTAL
Company Info
- First Approval
- 1975-01-08
- Latest
- 2026-02-17
- Applications
- 111